nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—bone cancer	0.139	0.519	CrCtD
Daunorubicin—Doxorubicin—bone cancer	0.128	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—bone cancer	0.112	0.341	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—bone cancer	0.103	0.316	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—bone cancer	0.0584	0.178	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—bone cancer	0.054	0.165	CiPCiCtD
Daunorubicin—CYP3A4—bone cancer	0.0412	1	CbGaD
Daunorubicin—YWHAG—Epirubicin—bone cancer	0.0353	0.228	CbGbCtD
Daunorubicin—Idarubicin—Epirubicin—bone cancer	0.0297	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—bone cancer	0.0297	0.173	CrCrCtD
Daunorubicin—Doxorubicin—Epirubicin—bone cancer	0.0297	0.173	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—bone cancer	0.0275	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—bone cancer	0.0275	0.16	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—bone cancer	0.0275	0.16	CrCrCtD
Daunorubicin—YWHAG—Doxorubicin—bone cancer	0.0188	0.121	CbGbCtD
Daunorubicin—ABCC6—Cisplatin—bone cancer	0.0107	0.069	CbGbCtD
Daunorubicin—XDH—Carboplatin—bone cancer	0.00782	0.0504	CbGbCtD
Daunorubicin—POR—Doxorubicin—bone cancer	0.00779	0.0503	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—bone cancer	0.00717	0.0463	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—bone cancer	0.00716	0.0462	CbGbCtD
Daunorubicin—XDH—Cisplatin—bone cancer	0.00668	0.0431	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—bone cancer	0.00547	0.0353	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—bone cancer	0.0053	0.0342	CbGbCtD
Daunorubicin—XDH—Doxorubicin—bone cancer	0.00448	0.0289	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—bone cancer	0.00398	0.0257	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—bone cancer	0.00381	0.0246	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—bone cancer	0.00298	0.0192	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—bone cancer	0.00298	0.0192	CbGbCtD
Daunorubicin—SLC22A2—Cisplatin—bone cancer	0.00286	0.0184	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—bone cancer	0.00273	0.0176	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—bone cancer	0.00247	0.0159	CbGbCtD
Daunorubicin—ABCC2—Cisplatin—bone cancer	0.00233	0.0151	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—bone cancer	0.00211	0.0136	CbGbCtD
Daunorubicin—ABCG2—Cisplatin—bone cancer	0.00211	0.0136	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—bone cancer	0.00205	0.0132	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—bone cancer	0.00156	0.0101	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—bone cancer	0.00152	0.00978	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—bone cancer	0.00141	0.00912	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—bone cancer	0.00137	0.00884	CbGbCtD
Daunorubicin—ABCB1—Cisplatin—bone cancer	0.000761	0.00491	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—bone cancer	0.00051	0.00329	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—bone cancer	0.000494	0.00319	CbGbCtD
Daunorubicin—CYP3A4—Doxorubicin—bone cancer	0.000306	0.00197	CbGbCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—bone cancer	8.7e-05	0.26	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—bone cancer	8.7e-05	0.26	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—bone cancer	8.05e-05	0.24	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—bone cancer	8.05e-05	0.24	CbGdCrCtD
Daunorubicin—Menopausal symptoms—Epirubicin—bone cancer	3.74e-05	0.0017	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Doxorubicin—bone cancer	3.73e-05	0.00169	CcSEcCtD
Daunorubicin—Malaise—Cisplatin—bone cancer	3.73e-05	0.00169	CcSEcCtD
Daunorubicin—Renal impairment—Epirubicin—bone cancer	3.7e-05	0.00168	CcSEcCtD
Daunorubicin—Leukopenia—Cisplatin—bone cancer	3.7e-05	0.00168	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Epirubicin—bone cancer	3.64e-05	0.00165	CcSEcCtD
Daunorubicin—Eye pain—Doxorubicin—bone cancer	3.61e-05	0.00164	CcSEcCtD
Daunorubicin—Cardiac failure—Epirubicin—bone cancer	3.61e-05	0.00164	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Doxorubicin—bone cancer	3.6e-05	0.00163	CcSEcCtD
Daunorubicin—Convulsion—Cisplatin—bone cancer	3.58e-05	0.00163	CcSEcCtD
Daunorubicin—Mood swings—Methotrexate—bone cancer	3.57e-05	0.00162	CcSEcCtD
Daunorubicin—Ataxia—Methotrexate—bone cancer	3.54e-05	0.00161	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Epirubicin—bone cancer	3.53e-05	0.0016	CcSEcCtD
Daunorubicin—Myalgia—Cisplatin—bone cancer	3.52e-05	0.0016	CcSEcCtD
Daunorubicin—Anxiety—Cisplatin—bone cancer	3.51e-05	0.00159	CcSEcCtD
Daunorubicin—Hot flush—Doxorubicin—bone cancer	3.49e-05	0.00158	CcSEcCtD
Daunorubicin—Discomfort—Cisplatin—bone cancer	3.48e-05	0.00158	CcSEcCtD
Daunorubicin—Increased appetite—Doxorubicin—bone cancer	3.47e-05	0.00158	CcSEcCtD
Daunorubicin—Affect lability—Epirubicin—bone cancer	3.47e-05	0.00157	CcSEcCtD
Daunorubicin—Menopausal symptoms—Doxorubicin—bone cancer	3.46e-05	0.00157	CcSEcCtD
Daunorubicin—Renal impairment—Doxorubicin—bone cancer	3.43e-05	0.00156	CcSEcCtD
Daunorubicin—Anaphylactic shock—Cisplatin—bone cancer	3.37e-05	0.00153	CcSEcCtD
Daunorubicin—Oedema—Cisplatin—bone cancer	3.37e-05	0.00153	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—bone cancer	3.37e-05	0.00153	CcSEcCtD
Daunorubicin—Cardiac arrest—Epirubicin—bone cancer	3.35e-05	0.00152	CcSEcCtD
Daunorubicin—Infection—Cisplatin—bone cancer	3.35e-05	0.00152	CcSEcCtD
Daunorubicin—Cardiac failure—Doxorubicin—bone cancer	3.34e-05	0.00152	CcSEcCtD
Daunorubicin—Mood swings—Epirubicin—bone cancer	3.34e-05	0.00152	CcSEcCtD
Daunorubicin—Ataxia—Epirubicin—bone cancer	3.31e-05	0.0015	CcSEcCtD
Daunorubicin—Thrombocytopenia—Cisplatin—bone cancer	3.3e-05	0.0015	CcSEcCtD
Daunorubicin—Tachycardia—Cisplatin—bone cancer	3.29e-05	0.00149	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—bone cancer	3.28e-05	0.00149	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	3.26e-05	0.00148	CcSEcCtD
Daunorubicin—Hyperhidrosis—Cisplatin—bone cancer	3.26e-05	0.00148	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—bone cancer	3.23e-05	0.00147	CcSEcCtD
Daunorubicin—Anorexia—Cisplatin—bone cancer	3.22e-05	0.00146	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—bone cancer	3.21e-05	0.00146	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—bone cancer	3.12e-05	0.00142	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—bone cancer	3.1e-05	0.00141	CcSEcCtD
Daunorubicin—Pancytopenia—Methotrexate—bone cancer	3.09e-05	0.0014	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—bone cancer	3.09e-05	0.0014	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Cisplatin—bone cancer	3.07e-05	0.00139	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—bone cancer	3.07e-05	0.00139	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—bone cancer	3.05e-05	0.00138	CcSEcCtD
Daunorubicin—Neutropenia—Methotrexate—bone cancer	3.04e-05	0.00138	CcSEcCtD
Daunorubicin—Dysuria—Methotrexate—bone cancer	3.04e-05	0.00138	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—bone cancer	3.03e-05	0.00138	CcSEcCtD
Daunorubicin—Dyspnoea—Cisplatin—bone cancer	3.01e-05	0.00137	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—bone cancer	2.99e-05	0.00136	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—bone cancer	2.97e-05	0.00135	CcSEcCtD
Daunorubicin—Decreased appetite—Cisplatin—bone cancer	2.93e-05	0.00133	CcSEcCtD
Daunorubicin—Depression—Methotrexate—bone cancer	2.89e-05	0.00131	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—bone cancer	2.89e-05	0.00131	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—bone cancer	2.89e-05	0.00131	CcSEcCtD
Daunorubicin—Pain—Cisplatin—bone cancer	2.89e-05	0.00131	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—bone cancer	2.85e-05	0.00129	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—bone cancer	2.85e-05	0.00129	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—bone cancer	2.85e-05	0.00129	CcSEcCtD
Daunorubicin—Stomatitis—Methotrexate—bone cancer	2.83e-05	0.00128	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—bone cancer	2.82e-05	0.00128	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—bone cancer	2.82e-05	0.00128	CcSEcCtD
Daunorubicin—Feeling abnormal—Cisplatin—bone cancer	2.78e-05	0.00126	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—bone cancer	2.75e-05	0.00125	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—bone cancer	2.68e-05	0.00121	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—bone cancer	2.67e-05	0.00121	CcSEcCtD
Daunorubicin—Body temperature increased—Cisplatin—bone cancer	2.67e-05	0.00121	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—bone cancer	2.66e-05	0.00121	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—bone cancer	2.65e-05	0.0012	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—bone cancer	2.64e-05	0.0012	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—bone cancer	2.64e-05	0.0012	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—bone cancer	2.64e-05	0.0012	CcSEcCtD
Daunorubicin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.57e-05	0.00163	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—BRAF—bone cancer	2.57e-05	0.00162	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	2.57e-05	0.00162	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	2.56e-05	0.00162	CbGpPWpGaD
Daunorubicin—Sinusitis—Epirubicin—bone cancer	2.55e-05	0.00116	CcSEcCtD
Daunorubicin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	2.54e-05	0.0016	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MDM2—bone cancer	2.54e-05	0.0016	CbGpPWpGaD
Daunorubicin—Visual impairment—Methotrexate—bone cancer	2.51e-05	0.00114	CcSEcCtD
Daunorubicin—Hypersensitivity—Cisplatin—bone cancer	2.49e-05	0.00113	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	2.47e-05	0.00156	CbGpPWpGaD
Daunorubicin—Renal failure—Doxorubicin—bone cancer	2.47e-05	0.00112	CcSEcCtD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	2.47e-05	0.00156	CbGpPWpGaD
Daunorubicin—Neuropathy peripheral—Doxorubicin—bone cancer	2.46e-05	0.00112	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	2.46e-05	0.00156	CbGpPWpGaD
Daunorubicin—Stomatitis—Doxorubicin—bone cancer	2.45e-05	0.00111	CcSEcCtD
Daunorubicin—NR5A1—Gene Expression—NR1I2—bone cancer	2.45e-05	0.00155	CbGpPWpGaD
Daunorubicin—Rhinitis—Epirubicin—bone cancer	2.44e-05	0.00111	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—bone cancer	2.44e-05	0.00111	CcSEcCtD
Daunorubicin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	2.44e-05	0.00154	CbGpPWpGaD
Daunorubicin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.43e-05	0.00154	CbGpPWpGaD
Daunorubicin—Tinnitus—Methotrexate—bone cancer	2.43e-05	0.0011	CcSEcCtD
Daunorubicin—Asthenia—Cisplatin—bone cancer	2.42e-05	0.0011	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—bone cancer	2.42e-05	0.0011	CcSEcCtD
Daunorubicin—XDH—Selenium Micronutrient Network—PTGS2—bone cancer	2.4e-05	0.00152	CbGpPWpGaD
Daunorubicin—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	2.4e-05	0.00152	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	2.37e-05	0.0015	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	2.36e-05	0.00149	CbGpPWpGaD
Daunorubicin—Sinusitis—Doxorubicin—bone cancer	2.36e-05	0.00107	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—bone cancer	2.35e-05	0.00107	CcSEcCtD
Daunorubicin—Chills—Methotrexate—bone cancer	2.34e-05	0.00106	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	2.34e-05	0.00148	CbGpPWpGaD
Daunorubicin—Diarrhoea—Cisplatin—bone cancer	2.31e-05	0.00105	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	2.3e-05	0.00146	CbGpPWpGaD
Daunorubicin—Alopecia—Methotrexate—bone cancer	2.3e-05	0.00105	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—bone cancer	2.27e-05	0.00103	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—bone cancer	2.27e-05	0.00103	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—bone cancer	2.26e-05	0.00103	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—bone cancer	2.26e-05	0.00103	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—bone cancer	2.26e-05	0.00103	CcSEcCtD
Daunorubicin—CYP1B1—Tryptophan metabolism—MDM2—bone cancer	2.24e-05	0.00142	CbGpPWpGaD
Daunorubicin—Dysgeusia—Methotrexate—bone cancer	2.22e-05	0.00101	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—bone cancer	2.19e-05	0.000996	CcSEcCtD
Daunorubicin—Chills—Epirubicin—bone cancer	2.19e-05	0.000993	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—bone cancer	2.18e-05	0.000989	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—bone cancer	2.17e-05	0.000987	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	2.16e-05	0.00137	CbGpPWpGaD
Daunorubicin—Alopecia—Epirubicin—bone cancer	2.16e-05	0.000978	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—JUN—bone cancer	2.15e-05	0.00136	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	2.15e-05	0.00136	CbGpPWpGaD
Daunorubicin—Vomiting—Cisplatin—bone cancer	2.15e-05	0.000973	CcSEcCtD
Daunorubicin—Rash—Cisplatin—bone cancer	2.13e-05	0.000965	CcSEcCtD
Daunorubicin—Dermatitis—Cisplatin—bone cancer	2.13e-05	0.000964	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—bone cancer	2.12e-05	0.000963	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—TUBB4B—bone cancer	2.12e-05	0.00134	CbGpPWpGaD
Daunorubicin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	2.11e-05	0.00133	CbGpPWpGaD
Daunorubicin—Ill-defined disorder—Methotrexate—bone cancer	2.1e-05	0.000955	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—bone cancer	2.1e-05	0.000955	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—bone cancer	2.1e-05	0.000952	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—bone cancer	2.09e-05	0.00095	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—bone cancer	2.09e-05	0.00095	CcSEcCtD
Daunorubicin—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	2.09e-05	0.00132	CbGpPWpGaD
Daunorubicin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.09e-05	0.00132	CbGpPWpGaD
Daunorubicin—Dysgeusia—Epirubicin—bone cancer	2.08e-05	0.000943	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—bone cancer	2.05e-05	0.000932	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—bone cancer	2.05e-05	0.000928	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—bone cancer	2.03e-05	0.000922	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—bone cancer	2.02e-05	0.000919	CcSEcCtD
Daunorubicin—CYP1B1—Arachidonic acid metabolism—PTGS2—bone cancer	2.02e-05	0.00128	CbGpPWpGaD
Daunorubicin—Arrhythmia—Doxorubicin—bone cancer	2.02e-05	0.000915	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	2.01e-05	0.00127	CbGpPWpGaD
Daunorubicin—Nausea—Cisplatin—bone cancer	2e-05	0.000909	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—bone cancer	1.99e-05	0.000905	CcSEcCtD
Daunorubicin—Cough—Methotrexate—bone cancer	1.98e-05	0.000898	CcSEcCtD
Daunorubicin—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.97e-05	0.00125	CbGpPWpGaD
Daunorubicin—Ill-defined disorder—Epirubicin—bone cancer	1.97e-05	0.000894	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—bone cancer	1.97e-05	0.000892	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—bone cancer	1.96e-05	0.000891	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—bone cancer	1.96e-05	0.00089	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.95e-05	0.00123	CbGpPWpGaD
Daunorubicin—Agitation—Epirubicin—bone cancer	1.95e-05	0.000885	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.95e-05	0.00123	CbGpPWpGaD
Daunorubicin—Arthralgia—Methotrexate—bone cancer	1.93e-05	0.000876	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—bone cancer	1.93e-05	0.000876	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—bone cancer	1.93e-05	0.000876	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—RFC1—bone cancer	1.92e-05	0.00122	CbGpPWpGaD
Daunorubicin—Dysgeusia—Doxorubicin—bone cancer	1.92e-05	0.000873	CcSEcCtD
Daunorubicin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	1.92e-05	0.00121	CbGpPWpGaD
Daunorubicin—Malaise—Epirubicin—bone cancer	1.91e-05	0.000869	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	1.91e-05	0.00121	CbGpPWpGaD
Daunorubicin—Discomfort—Methotrexate—bone cancer	1.91e-05	0.000866	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—DHFR—bone cancer	1.91e-05	0.00121	CbGpPWpGaD
Daunorubicin—Syncope—Epirubicin—bone cancer	1.9e-05	0.000864	CcSEcCtD
Daunorubicin—XDH—Metabolism—NDUFA12—bone cancer	1.9e-05	0.0012	CbGpPWpGaD
Daunorubicin—Leukopenia—Epirubicin—bone cancer	1.9e-05	0.000862	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—bone cancer	1.9e-05	0.000862	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—bone cancer	1.88e-05	0.000851	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—JUN—bone cancer	1.87e-05	0.00118	CbGpPWpGaD
Daunorubicin—Confusional state—Methotrexate—bone cancer	1.87e-05	0.000847	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—bone cancer	1.87e-05	0.000847	CcSEcCtD
Daunorubicin—Cough—Epirubicin—bone cancer	1.85e-05	0.000841	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—bone cancer	1.85e-05	0.00084	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—bone cancer	1.84e-05	0.000835	CcSEcCtD
Daunorubicin—Infection—Methotrexate—bone cancer	1.84e-05	0.000835	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—bone cancer	1.83e-05	0.000832	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—bone cancer	1.82e-05	0.000827	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—bone cancer	1.82e-05	0.000824	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—bone cancer	1.81e-05	0.000823	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—bone cancer	1.81e-05	0.00082	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—bone cancer	1.81e-05	0.00082	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—bone cancer	1.81e-05	0.00082	CcSEcCtD
Daunorubicin—NR5A1—Gene Expression—EIF2S1—bone cancer	1.81e-05	0.00114	CbGpPWpGaD
Daunorubicin—Agitation—Doxorubicin—bone cancer	1.81e-05	0.000819	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—bone cancer	1.8e-05	0.000817	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—bone cancer	1.79e-05	0.000812	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—bone cancer	1.79e-05	0.00081	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—bone cancer	1.77e-05	0.000804	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—bone cancer	1.77e-05	0.000802	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—bone cancer	1.76e-05	0.000801	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—bone cancer	1.76e-05	0.000799	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—bone cancer	1.76e-05	0.000798	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—bone cancer	1.75e-05	0.000793	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—bone cancer	1.74e-05	0.000788	CcSEcCtD
Daunorubicin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	1.73e-05	0.0011	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—GSTP1—bone cancer	1.73e-05	0.0011	CbGpPWpGaD
Daunorubicin—Oedema—Epirubicin—bone cancer	1.73e-05	0.000786	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—bone cancer	1.73e-05	0.000786	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—MET—bone cancer	1.73e-05	0.00109	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CDK4—bone cancer	1.73e-05	0.00109	CbGpPWpGaD
Daunorubicin—Loss of consciousness—Doxorubicin—bone cancer	1.73e-05	0.000783	CcSEcCtD
Daunorubicin—Infection—Epirubicin—bone cancer	1.72e-05	0.000781	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—bone cancer	1.71e-05	0.000778	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—DHFR—bone cancer	1.71e-05	0.00108	CbGpPWpGaD
Daunorubicin—Shock—Epirubicin—bone cancer	1.7e-05	0.000774	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—bone cancer	1.7e-05	0.000772	CcSEcCtD
Daunorubicin—CYP1B1—Biological oxidations—CYP3A4—bone cancer	1.7e-05	0.00107	CbGpPWpGaD
Daunorubicin—Thrombocytopenia—Epirubicin—bone cancer	1.7e-05	0.00077	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—bone cancer	1.7e-05	0.00077	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—EGFR—bone cancer	1.69e-05	0.00107	CbGpPWpGaD
Daunorubicin—Tachycardia—Epirubicin—bone cancer	1.69e-05	0.000767	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—bone cancer	1.69e-05	0.000765	CcSEcCtD
Daunorubicin—CYP1B1—Metapathway biotransformation—CYP3A4—bone cancer	1.68e-05	0.00106	CbGpPWpGaD
Daunorubicin—Hyperhidrosis—Epirubicin—bone cancer	1.68e-05	0.00076	CcSEcCtD
Daunorubicin—Insomnia—Methotrexate—bone cancer	1.67e-05	0.00076	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—bone cancer	1.67e-05	0.000759	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—bone cancer	1.67e-05	0.000759	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—bone cancer	1.67e-05	0.000759	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—bone cancer	1.67e-05	0.000756	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	1.66e-05	0.00105	CbGpPWpGaD
Daunorubicin—Discomfort—Doxorubicin—bone cancer	1.65e-05	0.00075	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—bone cancer	1.65e-05	0.000749	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—bone cancer	1.65e-05	0.000749	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—bone cancer	1.65e-05	0.000747	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—bone cancer	1.64e-05	0.000742	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	1.62e-05	0.00102	CbGpPWpGaD
Daunorubicin—Confusional state—Doxorubicin—bone cancer	1.62e-05	0.000734	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—bone cancer	1.61e-05	0.00073	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—bone cancer	1.6e-05	0.000728	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—bone cancer	1.6e-05	0.000728	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—bone cancer	1.6e-05	0.000724	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—bone cancer	1.59e-05	0.000723	CcSEcCtD
Daunorubicin—Pain—Methotrexate—bone cancer	1.58e-05	0.000718	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—bone cancer	1.58e-05	0.000716	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—bone cancer	1.58e-05	0.000716	CcSEcCtD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	1.58e-05	0.000996	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—NT5C3A—bone cancer	1.58e-05	0.000996	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—EZH2—bone cancer	1.57e-05	0.000992	CbGpPWpGaD
Daunorubicin—Thrombocytopenia—Doxorubicin—bone cancer	1.57e-05	0.000712	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—JUN—bone cancer	1.57e-05	0.000991	CbGpPWpGaD
Daunorubicin—Insomnia—Epirubicin—bone cancer	1.57e-05	0.000711	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—bone cancer	1.56e-05	0.00071	CcSEcCtD
Daunorubicin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	1.55e-05	0.000979	CbGpPWpGaD
Daunorubicin—Hyperhidrosis—Doxorubicin—bone cancer	1.55e-05	0.000703	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—bone cancer	1.54e-05	0.000701	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—bone cancer	1.54e-05	0.000699	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.53e-05	0.000969	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.53e-05	0.000969	CbGpPWpGaD
Daunorubicin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	1.53e-05	0.000966	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	1.53e-05	0.000965	CbGpPWpGaD
Daunorubicin—Anorexia—Doxorubicin—bone cancer	1.53e-05	0.000693	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—bone cancer	1.53e-05	0.000692	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—bone cancer	1.51e-05	0.000687	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—bone cancer	1.51e-05	0.000684	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—bone cancer	1.49e-05	0.000678	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—bone cancer	1.48e-05	0.000672	CcSEcCtD
Daunorubicin—Pain—Epirubicin—bone cancer	1.48e-05	0.000672	CcSEcCtD
Daunorubicin—Urticaria—Methotrexate—bone cancer	1.47e-05	0.000667	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—bone cancer	1.46e-05	0.000664	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—bone cancer	1.46e-05	0.000664	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—bone cancer	1.46e-05	0.000663	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—TP53—bone cancer	1.45e-05	0.000919	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—GSTP1—bone cancer	1.45e-05	0.000919	CbGpPWpGaD
Daunorubicin—Insomnia—Doxorubicin—bone cancer	1.45e-05	0.000658	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.45e-05	0.000915	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MMP2—bone cancer	1.45e-05	0.000913	CbGpPWpGaD
Daunorubicin—CYP1B1—Metapathway biotransformation—GSTP1—bone cancer	1.43e-05	0.000906	CbGpPWpGaD
Daunorubicin—Dyspnoea—Doxorubicin—bone cancer	1.43e-05	0.000649	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—bone cancer	1.43e-05	0.000648	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—CHEK2—bone cancer	1.43e-05	0.000901	CbGpPWpGaD
Daunorubicin—Somnolence—Doxorubicin—bone cancer	1.43e-05	0.000647	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—bone cancer	1.42e-05	0.000643	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—NDUFA12—bone cancer	1.4e-05	0.000886	CbGpPWpGaD
Daunorubicin—Decreased appetite—Doxorubicin—bone cancer	1.39e-05	0.000632	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	1.39e-05	0.000878	CbGpPWpGaD
Daunorubicin—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	1.38e-05	0.000873	CbGpPWpGaD
Daunorubicin—Fatigue—Doxorubicin—bone cancer	1.38e-05	0.000627	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—bone cancer	1.38e-05	0.000625	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—bone cancer	1.37e-05	0.000622	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—bone cancer	1.37e-05	0.000622	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—bone cancer	1.37e-05	0.000622	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—bone cancer	1.37e-05	0.000622	CcSEcCtD
Daunorubicin—Hypersensitivity—Methotrexate—bone cancer	1.36e-05	0.000619	CcSEcCtD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.36e-05	0.000861	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.35e-05	0.000851	CbGpPWpGaD
Daunorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	1.34e-05	0.000849	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	1.33e-05	0.000843	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.33e-05	0.000842	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	1.33e-05	0.000842	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	1.33e-05	0.00084	CbGpPWpGaD
Daunorubicin—Asthenia—Methotrexate—bone cancer	1.33e-05	0.000603	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—bone cancer	1.32e-05	0.0006	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—bone cancer	1.31e-05	0.000595	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—bone cancer	1.31e-05	0.000594	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—bone cancer	1.28e-05	0.000579	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—bone cancer	1.27e-05	0.000578	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—bone cancer	1.27e-05	0.000575	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—bone cancer	1.27e-05	0.000575	CcSEcCtD
Daunorubicin—Diarrhoea—Methotrexate—bone cancer	1.27e-05	0.000575	CcSEcCtD
Daunorubicin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.26e-05	0.000794	CbGpPWpGaD
Daunorubicin—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	1.25e-05	0.000787	CbGpPWpGaD
Daunorubicin—Asthenia—Epirubicin—bone cancer	1.24e-05	0.000564	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—bone cancer	1.23e-05	0.000556	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—bone cancer	1.22e-05	0.000556	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—BRCA2—bone cancer	1.21e-05	0.000763	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.2e-05	0.000759	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—DHFR—bone cancer	1.19e-05	0.000754	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.19e-05	0.000749	CbGpPWpGaD
Daunorubicin—Diarrhoea—Epirubicin—bone cancer	1.19e-05	0.000538	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—bone cancer	1.18e-05	0.000536	CcSEcCtD
Daunorubicin—Vomiting—Methotrexate—bone cancer	1.18e-05	0.000534	CcSEcCtD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.18e-05	0.000744	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.17e-05	0.000741	CbGpPWpGaD
Daunorubicin—Rash—Methotrexate—bone cancer	1.17e-05	0.00053	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—bone cancer	1.17e-05	0.000529	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.16e-05	0.000735	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NT5C3A—bone cancer	1.16e-05	0.000734	CbGpPWpGaD
Daunorubicin—Headache—Methotrexate—bone cancer	1.16e-05	0.000526	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	1.16e-05	0.00073	CbGpPWpGaD
Daunorubicin—Asthenia—Doxorubicin—bone cancer	1.15e-05	0.000522	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—bone cancer	1.15e-05	0.00052	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—bone cancer	1.13e-05	0.000515	CcSEcCtD
Daunorubicin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.11e-05	0.0007	CbGpPWpGaD
Daunorubicin—Vomiting—Epirubicin—bone cancer	1.1e-05	0.0005	CcSEcCtD
Daunorubicin—Nausea—Methotrexate—bone cancer	1.1e-05	0.000499	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—bone cancer	1.1e-05	0.000498	CcSEcCtD
Daunorubicin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.09e-05	0.00069	CbGpPWpGaD
Daunorubicin—Rash—Epirubicin—bone cancer	1.09e-05	0.000496	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—bone cancer	1.09e-05	0.000495	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.09e-05	0.000689	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MMP9—bone cancer	1.09e-05	0.000686	CbGpPWpGaD
Daunorubicin—Headache—Epirubicin—bone cancer	1.09e-05	0.000493	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.07e-05	0.000678	CbGpPWpGaD
Daunorubicin—Dizziness—Doxorubicin—bone cancer	1.06e-05	0.000481	CcSEcCtD
Daunorubicin—ABCC1—Metabolism—NDUFA12—bone cancer	1.05e-05	0.000666	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—CYP3A4—bone cancer	1.05e-05	0.000661	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—bone cancer	1.04e-05	0.000657	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.03e-05	0.000654	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	1.03e-05	0.000653	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	1.03e-05	0.000652	CbGpPWpGaD
Daunorubicin—Nausea—Epirubicin—bone cancer	1.03e-05	0.000467	CcSEcCtD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.02e-05	0.000647	CbGpPWpGaD
Daunorubicin—Vomiting—Doxorubicin—bone cancer	1.02e-05	0.000463	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—NDUFA12—bone cancer	1.02e-05	0.000644	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.01e-05	0.00064	CbGpPWpGaD
Daunorubicin—Rash—Doxorubicin—bone cancer	1.01e-05	0.000459	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—bone cancer	1.01e-05	0.000458	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—bone cancer	1e-05	0.000456	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK4—bone cancer	1e-05	0.000633	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CHEK2—bone cancer	9.97e-06	0.00063	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	9.76e-06	0.000617	CbGpPWpGaD
Daunorubicin—Nausea—Doxorubicin—bone cancer	9.52e-06	0.000432	CcSEcCtD
Daunorubicin—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.48e-06	0.000599	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	9.45e-06	0.000597	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.45e-06	0.000597	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.35e-06	0.000591	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	9.33e-06	0.000589	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.27e-06	0.000586	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NDUFA12—bone cancer	9.27e-06	0.000586	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NDUFA12—bone cancer	9.18e-06	0.00058	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK4—bone cancer	8.96e-06	0.000566	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—JUN—bone cancer	8.96e-06	0.000566	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—GSTP1—bone cancer	8.96e-06	0.000566	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	8.83e-06	0.000558	CbGpPWpGaD
Daunorubicin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	8.81e-06	0.000557	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—bone cancer	8.78e-06	0.000554	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NT5C3A—bone cancer	8.73e-06	0.000552	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—RB1—bone cancer	8.71e-06	0.00055	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	8.5e-06	0.000537	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—BRCA2—bone cancer	8.45e-06	0.000534	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.45e-06	0.000533	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NT5C3A—bone cancer	8.44e-06	0.000533	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.95e-06	0.000502	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—RB1—bone cancer	7.79e-06	0.000492	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.69e-06	0.000486	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NT5C3A—bone cancer	7.68e-06	0.000485	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	7.66e-06	0.000484	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NT5C3A—bone cancer	7.6e-06	0.00048	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.59e-06	0.000479	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	7.44e-06	0.00047	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	7.34e-06	0.000463	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.19e-06	0.000454	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	7.01e-06	0.000443	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ENO2—bone cancer	6.91e-06	0.000436	CbGpPWpGaD
Daunorubicin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.8e-06	0.00043	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	6.68e-06	0.000422	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MDM2—bone cancer	6.64e-06	0.00042	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NDUFA12—bone cancer	6.64e-06	0.00042	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	6.58e-06	0.000416	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.43e-06	0.000406	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.41e-06	0.000405	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—DHFR—bone cancer	6.41e-06	0.000405	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NDUFA12—bone cancer	6.28e-06	0.000396	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK4—bone cancer	6.27e-06	0.000396	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	6.24e-06	0.000394	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.16e-06	0.000389	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	6.1e-06	0.000385	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	6.02e-06	0.00038	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	6.02e-06	0.00038	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GNA11—bone cancer	5.99e-06	0.000378	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—bone cancer	5.91e-06	0.000374	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.71e-06	0.000361	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—BRAF—bone cancer	5.7e-06	0.00036	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.63e-06	0.000356	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.53e-06	0.00035	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NT5C3A—bone cancer	5.5e-06	0.000348	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—RB1—bone cancer	5.45e-06	0.000344	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP3A4—bone cancer	5.43e-06	0.000343	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NT5C3A—bone cancer	5.2e-06	0.000329	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ENO2—bone cancer	5.09e-06	0.000322	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NDUFA12—bone cancer	5.01e-06	0.000317	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MDM2—bone cancer	4.78e-06	0.000302	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.77e-06	0.000301	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—DHFR—bone cancer	4.72e-06	0.000298	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MDM2—bone cancer	4.65e-06	0.000294	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTP1—bone cancer	4.64e-06	0.000293	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ENO2—bone cancer	4.57e-06	0.000288	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GNA11—bone cancer	4.41e-06	0.000279	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.41e-06	0.000278	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.35e-06	0.000275	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—DHFR—bone cancer	4.24e-06	0.000268	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NT5C3A—bone cancer	4.15e-06	0.000262	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NDUFA12—bone cancer	4e-06	0.000253	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP3A4—bone cancer	4e-06	0.000253	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.98e-06	0.000252	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ENO2—bone cancer	3.82e-06	0.000242	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—bone cancer	3.81e-06	0.000241	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ENO2—bone cancer	3.7e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—DHFR—bone cancer	3.55e-06	0.000224	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.53e-06	0.000223	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—DHFR—bone cancer	3.43e-06	0.000217	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTP1—bone cancer	3.42e-06	0.000216	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.41e-06	0.000215	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ENO2—bone cancer	3.37e-06	0.000213	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ENO2—bone cancer	3.33e-06	0.00021	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNA11—bone cancer	3.32e-06	0.000209	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NT5C3A—bone cancer	3.32e-06	0.000209	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNA11—bone cancer	3.21e-06	0.000203	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DHFR—bone cancer	3.12e-06	0.000197	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DHFR—bone cancer	3.09e-06	0.000195	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NDUFA12—bone cancer	3.09e-06	0.000195	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.07e-06	0.000194	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFBR2—bone cancer	3.07e-06	0.000194	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP3A4—bone cancer	3.01e-06	0.00019	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.99e-06	0.000189	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNA11—bone cancer	2.92e-06	0.000184	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP3A4—bone cancer	2.91e-06	0.000184	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.89e-06	0.000183	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GNA11—bone cancer	2.89e-06	0.000182	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—bone cancer	2.67e-06	0.000168	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP3A4—bone cancer	2.65e-06	0.000167	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP3A4—bone cancer	2.62e-06	0.000165	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—bone cancer	2.57e-06	0.000162	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.56e-06	0.000162	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—bone cancer	2.49e-06	0.000157	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.42e-06	0.000153	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ENO2—bone cancer	2.41e-06	0.000152	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—bone cancer	2.41e-06	0.000152	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ENO2—bone cancer	2.28e-06	0.000144	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—bone cancer	2.26e-06	0.000143	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—bone cancer	2.24e-06	0.000141	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DHFR—bone cancer	2.24e-06	0.000141	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DHFR—bone cancer	2.11e-06	0.000133	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KIT—bone cancer	2.09e-06	0.000132	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNA11—bone cancer	2.09e-06	0.000132	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.03e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNA11—bone cancer	1.98e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—bone cancer	1.97e-06	0.000124	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.9e-06	0.00012	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ENO2—bone cancer	1.82e-06	0.000115	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP3A4—bone cancer	1.79e-06	0.000113	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.78e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—bone cancer	1.77e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DHFR—bone cancer	1.69e-06	0.000107	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MDM2—bone cancer	1.65e-06	0.000104	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—bone cancer	1.62e-06	0.000102	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—bone cancer	1.59e-06	0.0001	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNA11—bone cancer	1.58e-06	9.97e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—bone cancer	1.53e-06	9.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO2—bone cancer	1.45e-06	9.18e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP3A4—bone cancer	1.43e-06	9.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DHFR—bone cancer	1.35e-06	8.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—bone cancer	1.33e-06	8.41e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—bone cancer	1.29e-06	8.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNA11—bone cancer	1.26e-06	7.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—bone cancer	1.22e-06	7.73e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—bone cancer	1.17e-06	7.4e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—bone cancer	1.16e-06	7.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.14e-06	7.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.14e-06	7.18e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—bone cancer	1.13e-06	7.12e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO2—bone cancer	1.12e-06	7.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DHFR—bone cancer	1.04e-06	6.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—bone cancer	9.76e-07	6.17e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNA11—bone cancer	9.72e-07	6.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—bone cancer	8.4e-07	5.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—bone cancer	7.93e-07	5.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—bone cancer	7.54e-07	4.76e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—bone cancer	6.34e-07	4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—bone cancer	5.06e-07	3.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—bone cancer	3.9e-07	2.47e-05	CbGpPWpGaD
